Centogene Profit Margin 2019-2023 | CNTG

Current and historical gross margin, operating margin and net profit margin for Centogene (CNTG) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Centogene net profit margin as of June 30, 2023 is 0%.
Centogene Annual Profit Margins
Centogene Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.012B $0.050B
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.555B 21.44
Inspire Medical Systems (INSP) United States $6.945B 0.00
IRhythm Technologies (IRTC) United States $3.488B 0.00
Axonics (AXNX) United States $3.415B 0.00
10x Genomics (TXG) United States $3.330B 0.00
Enovis (ENOV) United States $3.062B 23.26
Azenta (AZTA) United States $2.825B 230.23
Olink Holding AB (publ) (OLK) Sweden $2.719B 0.00
Hims & Hers Health (HIMS) United States $2.550B 0.00
Privia Health (PRVA) United States $2.145B 95.16
Schrodinger (SDGR) United States $1.756B 0.00
Omnicell (OMCL) United States $1.278B 31.27
Phreesia (PHR) United States $1.224B 0.00
Definitive Healthcare (DH) United States $0.832B 0.00
Standard BioTools (LAB) United States $0.731B 0.00
Fulgent Genetics (FLGT) United States $0.609B 0.00
Talkspace (TALK) United States $0.530B 0.00
Health Catalyst (HCAT) United States $0.327B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.324B 0.00
Clover Health Investments (CLOV) United States $0.315B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.160B 0.00
Butterfly Network (BFLY) United States $0.159B 0.00
American Well (AMWL) United States $0.158B 0.00
Augmedix (AUGX) United States $0.146B 0.00
MSP Recovery (LIFW) United States $0.133B 0.00
TruBridge (TBRG) United States $0.121B 5.17
Outset Medical (OM) United States $0.120B 0.00
111 (YI) China $0.085B 0.00
SHL Telemedicine (SHLT) Israel $0.076B 0.00
Future Health ESG (FHLT) United States $0.064B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00